These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10788680)

  • 61. Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression.
    Maes M; Lin AH; Verkerk R; Delmeire L; Van Gastel A; Van der Planken M; Scharpé S
    Neuropsychopharmacology; 1999 Feb; 20(2):188-97. PubMed ID: 9885798
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.
    Cheetham SC; Viggers JA; Slater NA; Heal DJ; Buckett WR
    Neuropharmacology; 1993 Aug; 32(8):737-43. PubMed ID: 8413837
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter.
    Chudzik J; McCarthy D; Bakish D; Ravindran A; Hrdina PD
    Biochem Pharmacol; 1995 Oct; 50(8):1211-5. PubMed ID: 7488236
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.
    Figueras G; Pérez V; San Martino O; Alvarez E; Artigas F
    Biol Psychiatry; 1999 Aug; 46(4):518-24. PubMed ID: 10459402
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.
    Cupello A; Albano C; Gatta E; Scarrone S; Villa E; Zona G
    Neurochem Res; 2009 Feb; 34(2):255-9. PubMed ID: 18563559
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
    Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
    Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
    Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ
    Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers.
    Stein MB; Delaney SM; Chartier MJ; Kroft CD; Hazen AL
    Biol Psychiatry; 1995 Feb; 37(4):224-8. PubMed ID: 7711158
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of the platelet serotonin transporter by protein kinase C in the young and elderly.
    Marazziti D; Rossi A; Masala I; Rotondo A; Palego L; Mazzoni M; Giannaccini G; Lucacchini A; Cassano GB
    Biol Psychiatry; 1999 Feb; 45(4):443-7. PubMed ID: 10071715
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients.
    Arora RC; Fichtner CG; O'Connor F; Crayton JW
    Life Sci; 1993; 53(11):919-28. PubMed ID: 8366759
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
    Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
    Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Seasonal variation in platelet [3H]paroxetine binding in healthy volunteers. Relationship to climatic variables.
    D'Hondt P; Maes M; Leysen JE; Gommeren W; Heylen L; DeMeyer F; Scharpe S; Peeters D; Desnyder R
    Neuropsychopharmacology; 1996 Aug; 15(2):187-98. PubMed ID: 8840355
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Psychopharmacological treatment of aggression in schizophrenic patients.
    Brieden T; Ujeyl M; Naber D
    Pharmacopsychiatry; 2002 May; 35(3):83-9. PubMed ID: 12107851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
    Musselman DL; Marzec UM; Manatunga A; Penna S; Reemsnyder A; Knight BT; Baron A; Hanson SR; Nemeroff CB
    Arch Gen Psychiatry; 2000 Sep; 57(9):875-82. PubMed ID: 10986551
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
    Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
    Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Parameters of platelet serotonin system in patients with schizophrenia treated with olanzapine: a search for the serotonergic predictors of therapeutic efficacy].
    Brusov OS; Faktor MI; Zlobina GP; Dupin AM; Katasonov AB; Kartseva NK; Beniashvili AG; Zharkova NB; Rubashkina VV; Morozova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):27-34. PubMed ID: 15825226
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of washing procedure on platelets pretreated with serotonin uptake inhibitors in vitro: low Ki values predict long-lasting inhibition of serotonin uptake in vivo.
    Ishigooka J; Kasahara T; Nagata E; Murasaki M; Miura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):19-21. PubMed ID: 9592808
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
    Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serotonin uptake by platelets of suicidal and aggressive adolescent psychiatric inpatients.
    Modai I; Apter A; Meltzer M; Tyano S; Walevski A; Jerushalmy Z
    Neuropsychobiology; 1989; 21(1):9-13. PubMed ID: 2812295
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
    Bordet R; Thomas P; Dupuis B
    Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.